24 August 2020>: Lab/In Vitro Research
Olmutinib Reverses Doxorubicin Resistance in ETS1-Overexpressing Leukemia Cells
Jiansheng Zhong 1ABE* , Jinli Zhang 2AB , Xiaoyang Yu 3BF , Xing Zhang 1CD , Linping Dian 1CDDOI: 10.12659/MSM.924922
Med Sci Monit 2020; 26:e924922
Figure 3 The effect of olmutinib on apoptosis rate in K562 and K562/ADR cell lines overexpressing ETS1. Cell apoptosis of K562 (A) and K562/ADR (B) cells in different groups was assessed by flow cytometry (n=3). *** P<0.001 vs. Oe-NC+Dox; ## P<0.01 and ### P<0.001 vs. Oe-ETS1+Dox. Oe-NC – overexpression-negative control; Oe-ETS1 – overexpression-ETS1; Dox – doxorubicin; Olm – olmutinib.